FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993156615> ?p ?o ?g. }

• W1993156615 endingPage "501" @default.
• W1993156615 startingPage "493" @default.
• W1993156615 abstract "BACKGROUND Among patients with well differentiated papillary thyroid carcinoma who generally have an excellent prognosis and a near-normal lifespan, there exist subsets of patients who have significant risk for morbidity and mortality from this disease. It is important to define the patterns of disease progression and the clinical outcome of such patients to develop effective surveillance and treatment strategies. Patients with recurrence after surgery and therapeutic administration of radioactive iodine (RAI) for papillary thyroid carcinoma represent one such subset of high-risk patients. METHODS At The University of Texas M. D. Anderson Cancer Center, 65 patients with papillary thyroid carcinoma were diagnosed between 1970 and 1990. Their medical records were reviewed with particular attention to disease recurrence and outcome as well as RAI imaging and treatment. RESULTS Following diagnosis and initial therapy, 19 patients died from thyroid carcinoma after a median of 64 months; 34 had no evidence of disease for a median of 112 months of available follow-up; and 7 are alive with disease 61 to 153 months after diagnosis. Cervical lymph node metastases were present in 41 patients and extrathyroidal or extranodal tumor invasion was seen in 25 patients at the time of initial surgery; distant metastases (lung, bone, brain, liver, and adrenal) developed later in 18 patients. RAI uptake by recurrent tumor deposits in the neck was seen most frequently in patients with no direct invasion of adjacent tissues but with recurrence limited to cervical lymphadenopathy; this group of patients was the most likely to become clinically and radiologically disease free. RAI generally did not concentrate in invasive cancers with extrathyroidal or extranodal extension in the neck; patients with this type of invasive carcinoma were also more likely to die from the disease. CONCLUSIONS We suggest that among patients with recurrent papillary thyroid carcinoma, invasive cancers are less likely to concentrate RAI, whereas patients with disease confined to lymph nodes are more likely to have RAI-avid tumors and to benefit from RAI therapy. Cancer 1996;78:493-501." @default.
• W1993156615 created "2016-06-24" @default.
• W1993156615 creator A5052113684 @default.
• W1993156615 creator A5053233007 @default.
• W1993156615 creator A5084369725 @default.
• W1993156615 date "1996-08-01" @default.
• W1993156615 modified "2023-09-23" @default.
• W1993156615 title "Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy" @default.
• W1993156615 cites W130308683 @default.
• W1993156615 cites W1540717160 @default.
• W1993156615 cites W1597263227 @default.
• W1993156615 cites W1991149910 @default.
• W1993156615 cites W1998313745 @default.
• W1993156615 cites W2005600734 @default.
• W1993156615 cites W2010997285 @default.
• W1993156615 cites W2014664476 @default.
• W1993156615 cites W2016336194 @default.
• W1993156615 cites W2028080080 @default.
• W1993156615 cites W2028278716 @default.
• W1993156615 cites W2040826406 @default.
• W1993156615 cites W2054255592 @default.
• W1993156615 cites W2057836926 @default.
• W1993156615 cites W2057896103 @default.
• W1993156615 cites W2066187373 @default.
• W1993156615 cites W2072565358 @default.
• W1993156615 cites W2080705795 @default.
• W1993156615 cites W2085233478 @default.
• W1993156615 cites W2087440541 @default.
• W1993156615 cites W2088043936 @default.
• W1993156615 cites W2089602144 @default.
• W1993156615 cites W2091585840 @default.
• W1993156615 cites W2136505409 @default.
• W1993156615 cites W2152435308 @default.
• W1993156615 cites W2162544859 @default.
• W1993156615 cites W2312576106 @default.
• W1993156615 cites W2406273223 @default.
• W1993156615 cites W4230117866 @default.
• W1993156615 cites W4364324500 @default.
• W1993156615 cites W4378843396 @default.
• W1993156615 doi "https://doi.org/10.1002/(sici)1097-0142(19960801)78:3<493::aid-cncr17>3.0.co;2-u" @default.
• W1993156615 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8697396" @default.
• W1993156615 hasPublicationYear "1996" @default.
• W1993156615 type Work @default.
• W1993156615 sameAs 1993156615 @default.
• W1993156615 citedByCount "85" @default.
• W1993156615 countsByYear W19931566152012 @default.
• W1993156615 countsByYear W19931566152014 @default.
• W1993156615 countsByYear W19931566152015 @default.
• W1993156615 countsByYear W19931566152016 @default.
• W1993156615 countsByYear W19931566152017 @default.
• W1993156615 countsByYear W19931566152018 @default.
• W1993156615 countsByYear W19931566152019 @default.
• W1993156615 countsByYear W19931566152022 @default.
• W1993156615 countsByYear W19931566152023 @default.
• W1993156615 crossrefType "journal-article" @default.
• W1993156615 hasAuthorship W1993156615A5052113684 @default.
• W1993156615 hasAuthorship W1993156615A5053233007 @default.
• W1993156615 hasAuthorship W1993156615A5084369725 @default.
• W1993156615 hasBestOaLocation W19931566151 @default.
• W1993156615 hasConcept C121608353 @default.
• W1993156615 hasConcept C126322002 @default.
• W1993156615 hasConcept C126838900 @default.
• W1993156615 hasConcept C141071460 @default.
• W1993156615 hasConcept C2777074255 @default.
• W1993156615 hasConcept C2777546739 @default.
• W1993156615 hasConcept C2778549279 @default.
• W1993156615 hasConcept C2779013556 @default.
• W1993156615 hasConcept C2779134260 @default.
• W1993156615 hasConcept C2779761222 @default.
• W1993156615 hasConcept C2780849966 @default.
• W1993156615 hasConcept C2993294228 @default.
• W1993156615 hasConcept C526584372 @default.
• W1993156615 hasConcept C71924100 @default.
• W1993156615 hasConceptScore W1993156615C121608353 @default.
• W1993156615 hasConceptScore W1993156615C126322002 @default.
• W1993156615 hasConceptScore W1993156615C126838900 @default.
• W1993156615 hasConceptScore W1993156615C141071460 @default.
• W1993156615 hasConceptScore W1993156615C2777074255 @default.
• W1993156615 hasConceptScore W1993156615C2777546739 @default.
• W1993156615 hasConceptScore W1993156615C2778549279 @default.
• W1993156615 hasConceptScore W1993156615C2779013556 @default.
• W1993156615 hasConceptScore W1993156615C2779134260 @default.
• W1993156615 hasConceptScore W1993156615C2779761222 @default.
• W1993156615 hasConceptScore W1993156615C2780849966 @default.
• W1993156615 hasConceptScore W1993156615C2993294228 @default.
• W1993156615 hasConceptScore W1993156615C526584372 @default.
• W1993156615 hasConceptScore W1993156615C71924100 @default.
• W1993156615 hasIssue "3" @default.
• W1993156615 hasLocation W19931566151 @default.
• W1993156615 hasLocation W19931566152 @default.
• W1993156615 hasOpenAccess W1993156615 @default.
• W1993156615 hasPrimaryLocation W19931566151 @default.
• W1993156615 hasRelatedWork W1490422569 @default.
• W1993156615 hasRelatedWork W1586374228 @default.
• W1993156615 hasRelatedWork W2068477286 @default.
• W1993156615 hasRelatedWork W2364998975 @default.
• W1993156615 hasRelatedWork W2375384820 @default.
• W1993156615 hasRelatedWork W2376710390 @default.

• next